Enclave Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$750K Sell
1,805
-1,242
-41% -$460K 0.09% 80
2026
Q1
$824K Sell
3,047
-39
-1% -$11.6K 0.11% 77
2025
Q4
$1.02M Sell
3,086
-333
-10% -$113K 0.14% 69
2025
Q3
$1.18M Buy
3,419
+120
+4% +$36.3K 0.18% 57
2025
Q2
$1.03M Buy
3,299
+171
+5% +$65.4K 0.17% 60
2025
Q1
$1.64M Sell
3,128
-99
-3% -$50.6K 0.28% 49
2024
Q4
$1.63M Buy
3,227
+79
+3% +$44.9K 0.27% 47
2024
Q3
$1.84M Buy
+3,148
New +$1.78M 0.31% 43

Other funds holding UNH

Enclave Advisors's UNH Position: Q2 2026 in Review

Enclave Advisors reduced its UnitedHealth (UNH) stake by 41% in Q2 2026, selling an estimated $460K and leaving 1,805 shares worth $750K. The position accounts for 0.09% of the portfolio, ranked #80.

Enclave Advisors first reported a position in UNH in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.84M in Q3 2024. 1,855 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Enclave Advisors held 1,805 shares of UnitedHealth worth $750K as of Q2 2026.
  • Enclave Advisors sold 1,242 UnitedHealth shares in Q2 2026, an estimated $460K.
  • UnitedHealth made up 0.09% of Enclave Advisors's portfolio in Q2 2026, its #80 holding.
  • Enclave Advisors first reported a position in UnitedHealth in Q3 2024 and has held it in 8 quarters since.
  • Enclave Advisors's UnitedHealth position peaked at $1.84M in Q3 2024.
  • 1,855 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Enclave Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.